Industry NewsAstraZeneca progresses Ambition Zero Carbon program with Honeywell partnership to develop next-generation respiratory inhalers
Industry NewsAZD8601 EPICCURE Phase II trial demonstrated safety and tolerability in patients with heart failure
Industry NewsNew sub-analyses further support consistency of Farxiga’s cardiorenal and mortality benefits
Industry NewsAstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity
Industry NewsTagrisso approved in the EU for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer